Washington, DC 20006-5349
HELPLINE
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
Steve W. is a 56-year-old husband and father of three who was diagnosed with pleural mesothelioma in June 2018. Following his diagnosis, Steve and his
Bristol Myers Squibb announced today that CheckMate -743, a pivotal phase 3 trial evaluating Opdivo (nivolumab) in combination with Yervoy (ipilimumab) in previously untreated malignant pleural mesothelioma, met its primary endpoint of overall
Steve W. is a 56-year-old husband and father of three who was diagnosed with pleural mesothelioma in June 2018. Following his diagnosis, Steve and his
Steve W. is a 58-year-old husband and father of three who was diagnosed with pleural mesothelioma in June 2018. Following his diagnosis, Steve and his
Mary Hesdorffer, NP, executive director of the Mesothelioma Applied Research Foundation, interviewed mesothelioma expert Dr. Daniel Sterman, NYU, to discuss the current situation in New
In light of the current outbreak of the novel coronavirus disease, (known as COVID-19), we have consulted with medical experts on our Board of Directors
In light of current developments with regard to COVID-19, the International Symposium on Malignant Mesothelioma previously scheduled for April 6 and 7 in San Antonio, Texas, will be rescheduled. This decision comes after careful deliberation and
The Mesothelioma Applied Research Foundation is pleased to announce that Boris Sepesi, MD has joined its board of directors, the organization’s main governing board. Dr. Boris Sepesi is an associate professor in the department of thoracic and cardiovascular surgery at